These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32760196)

  • 1. LncRNA IGFBP4-1 promotes tumor development by activating Janus kinase-signal transducer and activator of transcription pathway in bladder urothelial carcinoma.
    Li C; Cao Y; Zhang L; Li J; Wu H; Ling F; Zheng J; Wang J; Li B; He J; Xie X; Li Z; Chen Y; He X; Guo M; Wei H; Ye J; Guo Y; Zhang S; Liu L; Liu G; Liu C
    Int J Biol Sci; 2020; 16(13):2271-2282. PubMed ID: 32760196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer.
    Huang W; Li Y; Zhang C; Zha H; Zhou X; Fu B; Guo J; Wang G
    J Cell Mol Med; 2020 Dec; 24(23):13949-13960. PubMed ID: 33094561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes.
    Yang W; Qian Y; Gao K; Zheng W; Wu G; He Q; Chen Q; Song Y; Wang L; Wang Y; Gu P; Chen B; Zhai R
    Carcinogenesis; 2021 Feb; 42(1):80-92. PubMed ID: 32459848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA-135528 inhibits tumor progression by up-regulating CXCL10 through the JAK/STAT pathway.
    Wang P; Peng X; Zhang J; Wang Z; Meng J; Cen B; Ji A; He S
    Apoptosis; 2018 Dec; 23(11-12):651-666. PubMed ID: 30232656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of LINC00691 promotes the proliferation and invasion of gastric cancer cells via the Janus kinase/signal transducer and activator of transcription signalling pathway.
    Liang W; Xia B; He C; Zhai G; Li M; Zhou J
    Int J Biochem Cell Biol; 2020 Jun; 123():105751. PubMed ID: 32330554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of lncRNA IGFBP4-1 reprograms energy metabolism to promote lung cancer progression.
    Yang B; Zhang L; Cao Y; Chen S; Cao J; Wu D; Chen J; Xiong H; Pan Z; Qiu F; Chen J; Ling X; Yan M; Huang S; Zhou S; Li T; Yang L; Huang Y; Lu J
    Mol Cancer; 2017 Sep; 16(1):154. PubMed ID: 28946875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder.
    Pei L; Yan D; He Q; Kong J; Yang M; Ruan H; Lin Q; Huang L; Huang J; Lin T; Qin H
    Cell Oncol (Dordr); 2023 Oct; 46(5):1509-1527. PubMed ID: 37355516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2.
    Ren W; Wu S; Wu Y; Liu T; Zhao X; Li Y
    Cell Death Dis; 2019 Apr; 10(5):333. PubMed ID: 30988277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowly expressed EGFR-AS1 promotes the progression of preeclampsia by inhibiting the EGFR-JAK/STAT signaling pathway.
    Zhao ZM; Jiang J
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6190-6197. PubMed ID: 30338781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways.
    Ito Y; Kanda M; Sasahara M; Tanaka C; Shimizu D; Umeda S; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
    Gastric Cancer; 2024 May; 27(3):506-518. PubMed ID: 38386237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-198 affects the proliferation and apoptosis of colorectal cancer through regulation of ADAM28/JAK-STAT signaling pathway.
    Li LX; Lam IH; Liang FF; Yi SP; Ye LF; Wang JT; Guo WW; Xu M
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1487-1493. PubMed ID: 30840270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
    Liu H; Chang JK; Hou JQ; Zhao ZH; Zhang LD
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3193-3199. PubMed ID: 28770966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSMA5 contributes to progression of lung adenocarcinoma in association with the JAK/STAT pathway.
    Lu F; Zhou J; Chen Q; Zhu J; Zheng X; Fang N; Qiao L
    Carcinogenesis; 2022 Aug; 43(7):624-634. PubMed ID: 35605971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA PART1 promotes progression of non-small cell lung cancer cells via JAK-STAT signaling pathway.
    Zhu D; Yu Y; Wang W; Wu K; Liu D; Yang Y; Zhang C; Qi Y; Zhao S
    Cancer Med; 2019 Oct; 8(13):6064-6081. PubMed ID: 31436388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway.
    Xiao C; Hong H; Yu H; Yuan J; Guo C; Cao H; Li W
    Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):278-283. PubMed ID: 29658372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The JAK-STAT signaling-related signature serves as a prognostic and predictive biomarker for renal cell carcinoma immunotherapy.
    Chan S; Liu Z; Chen Y; Chen S; Liang Y; Yang Z; Zhang Z; Li M; Zhang X; Liu X
    Gene; 2024 Nov; 927():148719. PubMed ID: 38917875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTHFD2 promotes PD-L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer.
    Li L; Zhang Y; Hu W; Zou F; Ning J; Rao T; Ruan Y; Yu W; Cheng F
    J Cell Mol Med; 2023 Oct; 27(19):2922-2936. PubMed ID: 37480214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obovatol inhibits the growth and aggressiveness of tongue squamous cell carcinoma through regulation of the EGF‑mediated JAK‑STAT signaling pathway.
    Duan M; Du X; Ren G; Zhang Y; Zheng Y; Sun S; Zhang J
    Mol Med Rep; 2018 Aug; 18(2):1651-1659. PubMed ID: 29845251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway.
    Li M; Zheng R; Yuan FL
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5987-5993. PubMed ID: 30280781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OTX1 silencing suppresses ovarian cancer progression through inhibiting the JAK/STAT signaling.
    Zhang Q; Li X; Ren L; Gu X; Xiao N; Li N
    Tissue Cell; 2023 Jun; 82():102082. PubMed ID: 37027968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.